Some objective considerations for the use of heparins and recombinant hirudin in percutaneous transluminal coronary angioplasty

Semin Thromb Hemost. 1991 Oct;17(4):455-70. doi: 10.1055/s-2007-1002655.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects*
  • Clinical Trials as Topic
  • Heparin / therapeutic use*
  • Hirudin Therapy*
  • Humans
  • Platelet Activation / drug effects
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Heparin